The drug, manufactured by Amgen, is the first of a novel class of agents known as bispecific T cell engagers (BiTE), which consist of essentially two monoclonal antibodies joined together. (cancerresearch.org)
But, the future appears brighter than ever before because there is a new class of agents, immunotherapies, which we now know can prolong survival and improve quality of life, with few side effects, in head and neck cancer,» said Dr. Ferris. (sciencedaily.com)
Multiple classes of agent with distinct mechanisms of action are now available for the treatment of patients with relapsed and / or refractory multiple myeloma (RRMM), including immunomodulatory agents, proteasome inhibitors, histone deacetylase inhibitors and monoclonal antibodies. (diseaseinfosearch.org)